Pricing

Ocular Therapeutix Inc (OCUL)

followers ·
Sector: HEALTH CARE
Industry: HEALTH CARE SUPPLIES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Antony Mattessich
Employees: 230
Web site: ocutx.com
24 CROSBY DRIVE, BEDFORD, MA, 01730
781-895-3235
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Ocular Therapeutix, Inc. focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retinal diseases.
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available